Pay in 4 interest-free payments of $6.64 Learn more
Ships within 48 hours · Estimated delivery Oct 22 - Oct 27
Clinical Comparison: Effectiveness, Dosing, Side Effects Effectiveness of tirzepatide: functioning as a dual GIP and GLP-1 receptor agonist, tirzepatide has demonstrated remarkable effectiveness in clinical studies, surpassing both semaglutide and placebo in terms of weight loss and glycemic control
Evidence-Based Results: GLP-1 therapy is supported by numerous clinical trials, with patients experiencing up to 15% body weight reduction on average
locations[0] } locations[0] } locations[0] } Hours Sun: locations[0] } Tue: locations[0] } Thu: locations[0] } Sat: locations[0] } locations[1] }, locations[1] } locations[1] } Mon: locations[1] } Wed: locations[1] } Fri: locations[1] }
Results: A total of 214 patients were included
Testing was discontinued at this dose due to extreme reductions in food intake
US$ 29.80
US$ 28.73
US$ 27.70
US$ 28.65
US$ 22.78
